Skip to main content

Table 2 Descriptive and univariate survival analysis according to treatment feature

From: Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study

Treatment characteristic

Median OS (months)

P value

CRLM surgery

 Yes

34

P < 0.0001

 No

10.6

Upfront CRLM surgery

 Yes

33

P = 0.3402

 No

34

Postoperative OS

28

NC

Exclusive chemotherapy

11.5

NC

FOLFIRINOX +/− bevacizumab

16.6

NC

  1. CRLM Colorectal liver metastases, OS Overall survival, NC Not concerned
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us